279 related articles for article (PubMed ID: 17700066)
1. DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'.
Bartek J; Lukas J; Bartkova J
Cell Cycle; 2007 Oct; 6(19):2344-7. PubMed ID: 17700066
[TBL] [Abstract][Full Text] [Related]
2. DNA damage signalling guards against activated oncogenes and tumour progression.
Bartek J; Bartkova J; Lukas J
Oncogene; 2007 Dec; 26(56):7773-9. PubMed ID: 18066090
[TBL] [Abstract][Full Text] [Related]
3. Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: implications for the anti-tumor barrier concept and treatment.
Bartkova J; Hoei-Hansen CE; Krizova K; Hamerlik P; Skakkebæk NE; Rajpert-De Meyts E; Bartek J
Mol Oncol; 2014 Dec; 8(8):1667-78. PubMed ID: 25066726
[TBL] [Abstract][Full Text] [Related]
4. The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer.
Tommiska J; Bartkova J; Heinonen M; Hautala L; Kilpivaara O; Eerola H; Aittomäki K; Hofstetter B; Lukas J; von Smitten K; Blomqvist C; Ristimäki A; Heikkilä P; Bartek J; Nevanlinna H
Oncogene; 2008 Apr; 27(17):2501-6. PubMed ID: 17982490
[TBL] [Abstract][Full Text] [Related]
5. Multiple roles of BRIT1/MCPH1 in DNA damage response, DNA repair, and cancer suppression.
Lin SY; Liang Y; Li K
Yonsei Med J; 2010 May; 51(3):295-301. PubMed ID: 20376879
[TBL] [Abstract][Full Text] [Related]
6. DNA damage response and repair in pancreatic cancer development and therapy.
Rahnamay Farnood P; Danesh Pazhooh R; Asemi Z; Yousefi B
DNA Repair (Amst); 2021 Jul; 103():103116. PubMed ID: 33882393
[TBL] [Abstract][Full Text] [Related]
7. DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours.
Bartkova J; Horejsí Z; Sehested M; Nesland JM; Rajpert-De Meyts E; Skakkebaek NE; Stucki M; Jackson S; Lukas J; Bartek J
Oncogene; 2007 Nov; 26(53):7414-22. PubMed ID: 17546051
[TBL] [Abstract][Full Text] [Related]
8. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
Arjumand W; Asiaf A; Ahmad ST
Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
[TBL] [Abstract][Full Text] [Related]
9. Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas.
Bartkova J; Hamerlik P; Stockhausen MT; Ehrmann J; Hlobilkova A; Laursen H; Kalita O; Kolar Z; Poulsen HS; Broholm H; Lukas J; Bartek J
Oncogene; 2010 Sep; 29(36):5095-102. PubMed ID: 20581868
[TBL] [Abstract][Full Text] [Related]
10. DNA damage repair in breast cancer and its therapeutic implications.
Ali R; Rakha EA; Madhusudan S; Bryant HE
Pathology; 2017 Feb; 49(2):156-165. PubMed ID: 28034453
[TBL] [Abstract][Full Text] [Related]
11. DNA damage response and prostate cancer: defects, regulation and therapeutic implications.
Karanika S; Karantanos T; Li L; Corn PG; Thompson TC
Oncogene; 2015 May; 34(22):2815-22. PubMed ID: 25132269
[TBL] [Abstract][Full Text] [Related]
12. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
Bartkova J; Horejsí Z; Koed K; Krämer A; Tort F; Zieger K; Guldberg P; Sehested M; Nesland JM; Lukas C; Ørntoft T; Lukas J; Bartek J
Nature; 2005 Apr; 434(7035):864-70. PubMed ID: 15829956
[TBL] [Abstract][Full Text] [Related]
13. Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.
Parikh AR; He Y; Hong TS; Corcoran RB; Clark JW; Ryan DP; Zou L; Ting DT; Catenacci DV; Chao J; Fakih M; Klempner SJ; Ross JS; Frampton GM; Miller VA; Ali SM; Schrock AB
Oncologist; 2019 Oct; 24(10):1340-1347. PubMed ID: 31040255
[TBL] [Abstract][Full Text] [Related]
14. The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response.
Brestovitsky A; Nebenzahl-Sharon K; Kechker P; Sharf R; Kleinberger T
PLoS Pathog; 2016 Feb; 12(2):e1005420. PubMed ID: 26867009
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence.
Graziano S; Johnston R; Deng O; Zhang J; Gonzalo S
Oncogene; 2016 Oct; 35(41):5362-5376. PubMed ID: 27041576
[TBL] [Abstract][Full Text] [Related]
16. DNA damage response and hematological malignancy.
Takagi M
Int J Hematol; 2017 Sep; 106(3):345-356. PubMed ID: 28374143
[TBL] [Abstract][Full Text] [Related]
17. DNA damage response--a double-edged sword in cancer prevention and cancer therapy.
Tian H; Gao Z; Li H; Zhang B; Wang G; Zhang Q; Pei D; Zheng J
Cancer Lett; 2015 Mar; 358(1):8-16. PubMed ID: 25528631
[TBL] [Abstract][Full Text] [Related]
18. DNA damage in cancer therapeutics: a boon or a curse?
Khanna A
Cancer Res; 2015 Jun; 75(11):2133-8. PubMed ID: 25931285
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer.
Sulli G; Di Micco R; d'Adda di Fagagna F
Nat Rev Cancer; 2012 Oct; 12(10):709-20. PubMed ID: 22952011
[TBL] [Abstract][Full Text] [Related]
20. DNA damage response in human testes and testicular germ cell tumours: biology and implications for therapy.
Bartkova J; Rajpert-De Meyts E; Skakkebaek NE; Lukas J; Bartek J
Int J Androl; 2007 Aug; 30(4):282-91; discussion 291. PubMed ID: 17573848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]